That number means nearly 11 percent of people who had sufficient time to get their second dose missed the ideal window, the Post reported July 2. That is an increase from 8 percent earlier in the year, which a CDC spokesperson told the Post was “not unexpected.”
The CDC considers a second dose to be missed if more than 42 days passed since the first dose. However, the CDC said individuals who don’t get the second shot in that time frame don’t have to start over to be fully vaccinated; there’s just less data on the effectiveness of a second dose received more than 42 days after the first, the Post reported.
Health officials have said people skip their second doses for various reasons, such as thinking they only need one to be protected and to avoid the side effects that can come with the second dose. Some simply miss their appointments and either can’t or don’t reschedule, the Post reported.
But health experts say getting both doses of an mRNA COVID-19 vaccine will be critical to combat the delta variant. A U.K. study published in May found that Pfizer’s vaccine was just 33 percent effective against the delta variant in preventing symptomatic disease after a single dose and 88 percent effective after two doses, the Post reported.
Read the full article here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
